Rivaroxaban, an oral, direct factor Xa inhibitor: a new option for thromboprophylaxis

Orthopedics. 2012 Nov;35(11):919; discussion 919. doi: 10.3928/01477447-20121101-17.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Factor Xa Inhibitors*
  • Humans
  • Morpholines / administration & dosage*
  • Postoperative Complications / prevention & control*
  • Thiophenes / administration & dosage*
  • Venous Thromboembolism / prevention & control*

Substances

  • Factor Xa Inhibitors
  • Morpholines
  • Thiophenes